Relay Therapeutics Announces Proposed Public Offering of Common Stock
CAMBRIDGE, Mass., Oct. 11, 2021 (GLOBE NEWSWIRE) — Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, announced…
